Krsnaa Diagnostics Chart
Krsnaa Diagnostics Share Key Metrics
Volume
1.15 L
Market Cap
1774.72 CR
LTQ@LTP
1@547.10
ATP
560.35
Var Margin
17.07 %
Circuit Range
459-688.4
Delivery %
61.47 %
Value
6.43 CR
ASM/GSM
No
Market Lot
1
Summary
Krsnaa Diagnostics Fundamentals
View MoreP/E Ratio
22.15
P/B Ratio
1.9
Div. Yield
0.5
Sector P/E
47.31
Sector P/B
-16.76
Sec. Div. Yield
2.66
Krsnaa Diagnostics Resistance and Support
Pivot 578.82
Resistance
First Resistance
589.79
Second Resistance
605.87
Third Resistance
616.84
Support
First Support
562.74
Second Support
551.77
Third Support
535.69
Krsnaa Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
Krsnaa Diagnostics News
About Krsnaa Diagnostics AboutThe
NSE : 5359
BSE : 543328
ISIN : INE08LI01020
The Company was originally incorporated as ‘Krsna Diagnostics Private Limited’ at Pune Maharashtra as a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation dated December 22 2010 issued by the RoC. The name of the Company was changed to ‘Krsnaa Diagnostics Private Limited’ pursuant to a fresh certificate of incorporation issued by the RoC on January 29 2015. Thereafter the Company was converted into a public limited company pursuant to a special resolution passed in the extraordinary general meeting of the Shareholders of the Company held on April 25 2021 and consequently the name of the Company was changed to its present name pursuant to a fresh certificate of incorporation issued by the RoC on May 6 2021.Major events and milestones of the Company :2011- Incorporation of the Company with two radiology centres2013- Started operating 12 centres in Himachal Pradesh in public private partnership2016- Investment by Somerset and Kitara in the Company2017- Completed installation of 50 centres in fthe states2018- Expanded operations across 13 states2019- Received accreditation from NABH for a centre in Madhya Pradesh2019- Investment by Phi Capital in the Company2020- Received accreditation from NABH and NABL for certain centres in Maharashtra Expanded to over 1500 centres across India- Received accreditation from NABL for certain centres in RajasthanKey awards accreditations or recognitions :2016- Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum2017- Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards2019- India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One2020- Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards- Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now- Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now
Krsnaa Diagnostics Management
| Name | Position |
|---|---|
| Mr. Rajendra Mutha | Chairman & Wholetime Director |
| Mr. Yash Mutha | Managing Director |
Krsnaa Diagnostics Similar Stocks
Solara Active Pharma Sciences Ltd.
442.70
-13.95 (3.05%)
Unichem Laboratories Ltd.
284.05
-14.65 (4.90%)
Hikal Ltd.
155.88
-9.45 (5.72%)
Morepen Laboratories Ltd.
36.15
-0.82 (2.22%)
Panacea Biotec Ltd.
321.50
-7.00 (2.13%)
Indoco Remedies Ltd.
173.46
-12.44 (6.69%)
Windlas Biotech Ltd.
765.00
-15.15 (1.94%)
Shalby Ltd.
131.04
-8.00 (5.75%)
Amrutanjan Health Care Ltd.
509.40
-9.80 (1.89%)
Krsnaa Diagnostics FAQs
